Research Results on FluMist Presented at National Association of,Pediatric Nurse Practitioners Conference ( bilityheadache chills vomiting mus...)

Research Results on FluMist Presented at National Association of,Pediatric Nurse Practitioners Conference

bility, headache, chills, vomiting, muscle aches, decreased appetite, abdominal pain, and decreased activity/feeling of tiredness/weakness.

Please see the Prescribing Information for the currently available formulation of FluMist, which is attached, or visit http://www.flumist.com, or call 1-877-633-4411 for additional information.

On January 5, 2007, the FDA approved MedImmune's supplemental Biologics Licensing Application (sBLA) for a refrigerated version of FluMist, which will be manufactured for the 2007-2008 influenza season. Prior versions required frozen storage. Due to the seasonal nature of influenza vaccine, full prescribing information for the refrigerated version does not yet contain complete details on vaccine strains to be included for next season's vaccine. However, preliminary prescribing information can be found by viewing the attachment.

About MedImmune, Inc.

MedImmune strives to provide better medicines to patients, new medical options for physicians, rewarding careers to employees, and increased value to shareholders. Dedicated to advancing science and medicine to help people live better lives, the company is focused on the areas of infectious diseases, cancer and inflammatory diseases. With more than 2,500 employees worldwide, MedImmune is headquartered in Maryland. For more information, visit the company's website at http://www.medimmune.com.

This announcement contains, in addition to historical information, certain "forward-looking statements" regarding the potential prospects of and the results of clinical trials for FluMist. Such forward-looking statements are based on current expectations and involve inherent risks and uncertainties, including factors that could delay, divert or change current expectations and could cause actual outcomes and results to differ materially from current expectation
'"/>

Page: 1 2 3 4 5 6
Related medicine technology :

1. NIEHS Researchers Identify Enzyme Critical in DNA Replication
2. Stanford Researchers Find Brain Pathway of Depression in Rats
3. Suven Life Sciences Presenting Pre-clinical data of their NCE’s SUVN-502 and SUVN-507at International Brain Research Organization (IBRO) 2007 World Congress of Neuroscience
4. From Clinical Cancer Research: Rethinking Therapeutic Cancer Vaccine Trials
5. Researchers Discover Method for Identifying How Cancer Evades the Immune System
6. Infertile Voice Supports Stem Cell Research: RESOLVE Calls for Patient Options in Using Frozen Embryos
7. Fact Sheet: Advancing Stem Cell Research While Respecting Moral Boundaries
8. President Bush Ignores Americas Plea for Support of Stem Cell Research
9. Researchers Discover Gene For Rare Skin Disorder
10. The Christopher and Dana Reeve Foundation Expresses Disappointment Over President Bushs Veto of the Stem Cell Research Enhancement Act
11. Research on New Treatment for Neglected Disease Published in The New England Journal of Medicine

Post Your Comments:

(Date:11/25/2009)...5 Reportlinker.com announces that ...atalogue: ,, United States Dental Devices Mark...ww.reportlinker.com/p0158733/United-States-Dental-... ,, United States Dental Devices Market Analys...s report is an essential source for in-depth infor...

(Date:11/25/2009).... 25 Abaxis, Inc. (Nasda...ng point-of-care blood analysis systems, announced...cutive officer, will present at the 21st Annual Pi...ecember 2, 2009 at 2:00 p.m. ET. The conference wi...k City. ,, About Abaxis ,, Abaxis develop...

(Date:11/25/2009)...Nov. 25 According to Millennium Re...l technology market intelligence, the nearly $3 bi...ontinue to see rapid growth over the next five yea... Markets for Trauma Devices 2010 report finds t...e next five years, with competitors introducing sp...

[0] Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 [0] Abaxis, Inc. to Present at the 21st Annual Piper Jaffray Health Care Conference [0] US Trauma Fixation Device Market Not Seeing Signs of Slowdown

...ith another stent hikes the risk of repeat blood ...March 29 When a clot develops inside a,coronary s...ially causing a,heart attack or even death. A sing... a new study suggests that one in six patients can... According to the Dutch Stent,Thrombosis Study, am...

...tor excel with high-dose clopidogrel on board?, C...ed,light on the ideal combination of medications f...hortly after percutaneous coronary intervention (P...etermine whether bivalirudin,a direct inhibitor of...ractionated heparin, an indirect thrombin inhibito...

Other Medicine Technology:Study Finds Repeated Episodes of Stent Thrombosis Common 2 Study Finds Repeated Episodes of Stent Thrombosis Common 3 ISAR-REACT 3 Pits Bivalirudin vs. Unfractionated Heparin in PCI 2 ISAR-REACT 3 Pits Bivalirudin vs. Unfractionated Heparin in PCI 3

Study Finds Repeated Episodes of Stent Thrombosis Common ISAR-REACT 3 Pits Bivalirudin vs. Unfractionated Heparin in PCI

(Date:11/27/2009)... cycling plus low-emission vehicles may reduce fut...FRIDAY, Nov. 27 (HealthDay News) -- Encouraging ci...ars would offer much greater public health benefit...K. researchers have found. , The study compared...ve urban land transport scenarios for London, Engl...

(Date:11/27/2009)... Specialist manufacturers who use me...e saving millions of dollars by bringing in techno...Increasing numbers of pro-active medical manufactu...he concept stage of their projects, ensuring that ...n processes or potentially outdated technology. ,...

(Date:11/26/2009)...r sequestering drug tetrathiomolybdate (TM) has be...nt of Wilson disease, a disease caused by an overl...t much is known. Very little, however, is known ab... A new study led by Northwestern University resear...ee-dimensional structure of TM bound to copper-loa...

(Date:11/26/2009)... Research Triangle Dental (RTDental)... Carolina, today announced the expansion of its se...R Dentist, Dr. Doug Macmillan. , ... Dental is pleased to announce that Dr. Doug Macmi... completed an additional advanced training seminar...

(Date:11/25/2009)..., EMERYVILLE, Calif., Nov. 25 /PRNewswire-FirstCa... ) today announced that the company will host two ... ,, December 7, 2009 - 9:00 a.m. CT/10:00 a...s data presentations surrounding carfilzomib in re...ured at the 51st American Society of Hematology (A...

Breaking Medicine News(10 mins):Health News:More Foot Power, Less Car Pollution Best for Health 2 Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2 Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3 Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4 Health News:Research sheds light on workings of anti-cancer drug 2 Health News:Research sheds light on workings of anti-cancer drug 3 Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2 Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2

[0] More Foot Power, Less Car Pollution Best for Health [0] Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells [1] Research sheds light on workings of anti-cancer drug [0] Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental [0] Onyx Pharmaceuticals Announces December 2009 Investor Events

...o protect all, studies show shots cut deaths, hosp...y News) -- The more people who get the flu vaccine...new studies. , In the first study, researchers fro...nce in 2000 helped lower flu-related deaths, hospi...

...ation and International Business Drive Top-Line Gr...er of Profitability, WESTFORD, Mass., Oct. 28 Cy... and manufacturer of a broad array of,light-based ...Results, Revenues increased to $38.2 million for ...

...nted Sunday, November 2, 2008 at this year,s liver... 31 - November 4, SAN FRANCISCO, Oct. 28 Researc..., led by Jennifer Kramer, Ph.D., looked at a,popul...us patients who have HIV are treated for HCV. This...

...., Oct. 28 Frost & Sullivan is,pleased to announc...ts 2008,Excellence in Healthcare Innovation Awards...at will take place on November 12, 2008 in San Ant...thcare.,Such companies have shown success at meeti...

...utive team has extensive medical device and financ...AIN VIEW, Calif., Oct. 28 PolyRemedy, Inc., a,man... fabrication and,tracking of customized, nano-mate... on October 14, 2008, and reports,directly to the ...

...NSUMERS LOOK TO MINIMALLY-INVASIVE PROCEDURES, CH...ooks matter for everyone from presidential candida...s forcing many consumers to re-evaluate,their cosm...ic meeting of the American Society of Plastic Surg...

When It Comes to Flu, the More Who Get Vaccine, the Better Cynosure Reports 21% Revenue Growth for the Third Quarter of 2008 Why Are Some Veterans Who Are Coinfected With Hepatitis C and HIV More Likely to Be Treated for HCV Than Others?Frost & Sullivan to Present the 2008 Excellence in Healthcare Innovation Awards PolyRemedy Hires Gary Coughlen as CFO Consumers and Plastic Surgeons Say Economy Is Cutting Into Cosmetic Procedures

EDM Ventricular Drainage Kit, with Drip Chamber

Lumbar External Drainage System (LED)

Monitorr ICP External CSF Drainage and Monitoring System

Skull Traction Tongs

Medicine Products:

EDM Ventricular Drainage Kit, with Drip Chamber Lumbar External Drainage System (LED)Monitorr ICP External CSF Drainage and Monitoring System Skull Traction Tongs

( bilityheadache chills vomiting mus...)Research Results on FluMist Presented at National Association of,Pediatric Nurse Practitioners Conference,Health